New Key Statistics Module, Z-Score and F-Score
NYSE:WST Key Ratios
Market Cap $ M | 24,140.95 |
Enterprise Value $ M | 23,845.75 |
P/E(ttm) | 43.72 |
PE Ratio without NRI | 43.27 |
Forward PE Ratio | 44.25 |
Price/Book | 9.03 |
Price/Sales | 8.48 |
Price/Free Cash Flow | 64.41 |
Price/Owner Earnings | 50.47 |
Payout Ratio % | 0.10 |
Revenue (TTM) $ M | 2,928.00 |
EPS (TTM) $ | 7.58 |
Beneish M-Score | -2.75 |
10-y EBITDA Growth Rate % | 15.00 |
5-y EBITDA Growth Rate % | 22.00 |
y-y EBITDA Growth Rate % | 5.70 |
EV-to-EBIT | 35.28 |
EV-to-EBITDA | 29.18 |
PEG | 1.97 |
Shares Outstanding M | 72.84 |
Net Margin (%) | 19.42 |
Operating Margin % | 22.71 |
Pre-tax Margin (%) | 22.79 |
Quick Ratio | 1.95 |
Current Ratio | 2.61 |
ROA % (ttm) | 15.30 |
ROE % (ttm) | 20.38 |
ROIC % (ttm) | 21.53 |
Dividend Yield % | 0.24 |
Altman Z-Score | 18.90 |
WST Number of Guru Trades
WST Volume of Guru Trades
Gurus Latest Trades with NYSE:WST
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:WST is held by these investors
Total 4
West Pharmaceutical Services Inc Insider Transactions
No Available Data
News about NYSE:WST
Total 0- 1